Found 7 results
Author Title [ Type(Desc)] Year
Filters: Author is Iversen, P L  [Clear All Filters]
Journal Article
G. McClorey, Moulton, H. M., Iversen, P. L., Fletcher, S., and Wilton, S. D., “Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.”, Gene therapy, vol. 13, no. 19, pp. 1373-81, 2006.
N. B. Marshall, Oda, S. K., London, C. A., Moulton, H. M., Iversen, P. L., Kerkvliet, N. I., and Mourich, D. V., “Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing.”, Journal of immunological methods, vol. 325, no. 1-2, pp. 114-26, 2007.
H. M. Moulton, Fletcher, S., Neuman, B. W., McClorey, G., Stein, D. A., Abes, S., Wilton, S. D., Buchmeier, M. J., Lebleu, B., and Iversen, P. L., “Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.”, Biochemical Society transactions, vol. 35, no. Pt 4, pp. 826-8, 2007.
R. Abes, Arzumanov, A. A., Moulton, H. M., Abes, S., Ivanova, G. D., Iversen, P. L., Gait, M. J., and Lebleu, B., “Cell-penetrating-peptide-based delivery of oligonucleotides: an overview.”, Biochemical Society transactions, vol. 35, no. Pt 4, pp. 775-9, 2007.
G. McClorey, Fall, A. M., Moulton, H. M., Iversen, P. L., Rasko, J. E., Ryan, M., Fletcher, S., and Wilton, S. D., “Induced dystrophin exon skipping in human muscle explants.”, Neuromuscular disorders : NMD, vol. 16, no. 9-10, pp. 583-90, 2006.
T. S. Deas, Binduga-Gajewska, I., Tilgner, M., Ren, P., Stein, D. A., Moulton, H. M., Iversen, P. L., Kauffman, E. B., Kramer, L. D., and Shi, P. Y., “Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.”, J Virol, vol. 79, no. 8, pp. 4599-609, 2005.
B. L. Geller, Deere, J. D., Stein, D. A., Kroeker, A. D., Moulton, H. M., and Iversen, P. L., “Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.”, Antimicrobial agents and chemotherapy, vol. 47, no. 10, pp. 3233-9, 2003.